ArticlePharmacy (Basel, Switzerland)2020

Assessing Pharmacists' Preferences towards Efficacy Attributes of Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis.

Iciar Martínez-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.